UsefulFor | Usefulforplasmin |
Formulation | DMSO |
Concentration | 10mM |
KineticProperties | KM |
KcatNDNDNDNDNDNDND3.7Kcat/KMNDNDNDNDNDNDND0.28|||SN-7 | |
6-amino-1-naphthalenesulfonamide-based(ANSN)fluorogenicsubstrate|||Structure | Mes-D-LGR-ANSN(C2H5)2 |
UsefulFor | UsefulforfactorXa |
Formulation | DMSO |
Concentration | 10mM |
KineticProperties | KM |
Kcat0.630.0070.7936150.055NDNDKcat/KM0.20.00040.042.90.260.005NDND|||SN-13a | |
6-amino-1-naphthalenesulfonamide-based(ANSN)fluorogenicsubstrate|||Structure | D-LPR-ANSNH-C3H7•2HCl |
UsefulFor | UsefulforfactorXIa |
Formulation | DMSO |
Concentration | 10mM |
KineticProperties | KM |
Kcat190.074.53.353520.31NDKcat/KM3800.0020.150.197.1120.03ND|||SN-17a | |
6-amino-1-naphthalenesulfonamide-based(ANSN)fluorogenicsubstrate|||Structure | D-FPR-ANSNH-C6H11•2HCl |
UsefulFor | UsefulforThrombin&VIIa |
Formulation | DMSO |
Concentration | 10mM |
KineticProperties | KM |
Kcat170.058.40.32ND6.60.074NDKcat/KM4300.0040.250.02ND8.60.02ND|||SN-17c | |
6-amino-1-naphthalenesulfonamide-based(ANSN)fluorogenicsubstrate|||Structure | D-FPR-ANSNH-C4H9•2HCl |
UsefulFor | UsefulforfactorVIIa |
Formulation | DMSO |
Concentration | 10mM |
KineticProperties | KM |
KcatND0.112.7NDND21NDNDKcat/KMND0.0060.26NDND4NDND|||SN-18 | |
6-amino-1-naphthalenesulfonamide-based(ANSN)fluorogenicsubstrate|||Structure | Boc-L-(p-F)FPR-ANSNH-C2H5 |
UsefulFor | UsefulfortPA |
Formulation | DMSO |
Concentration | 10mM |
KineticProperties | KM |
Kcat440.0080.88NDNDND1.03NDKcat/KM1200.0020.04NDNDND0.15ND|||SN-20 | |
6-amino-1-naphthalenesulfonamide-based(ANSN)fluorogenicsubstrate|||Structure | Boc-L-FPR-ANSNH-C2H5 |
UsefulFor | Usefulforthrombin |
Formulation | DMSO |
Concentration | 10mM |
KineticProperties | KM |
Kcat58NDND0.31ND2.20.011NDKcat/KM34NDND0.003ND0.040.002ND|||SN-45 | |
6-amino-1-naphthalenesulfonamide-based(ANSN)fluorogenicsubstrate|||Structure | L-EGR-ANSNH-C3H7•2HBr |
UsefulFor | UsefulforfactorXIa |
Formulation | DMSO |
Concentration | 10mM |
KineticProperties | KM |
Kcat2.5NDND0.28217NDNDKcat/KM0.25NDND0.023.60.39NDND|||SN-54 | |
6-amino-1-naphthalenesulfonamide-based(ANSN)fluorogenicsubstrate|||Structure | BOC-D-VLR-ANSNH-C4H9 |
UsefulFor | UsefulforaPC |
Formulation | DMSO |
Concentration | 10mM |
KineticProperties | KM |
Kcat0.0550.0071.60.055ND2.1NDNDKcat/KM0.030.0020.090.03ND5.2NDND|||SN-59 | |
6-amino-1-naphthalenesulfonamide-based(ANSN)fluorogenicsubstrate|||Structure | D-VPR-ANSNH-C4H9•2HCl |
UsefulFor | Usefulforthrombin&aPC |
Formulation | DMSO |
Concentration | 10mM |
KineticProperties | KM |
Kcat1100.0190.763.392720.71NDKcat/KM5500.0020.140.211.8130.065ND |
Nooverviewavailable.
Nopropertiesavailable.
Haemtech生物制药服务(HBS)是一家领先的,符合cGMP要求的QC测试实验室,专门为生产重组和血浆衍生蛋白疗法的生物制药制造商提供分析服务,重点是那些会影响止血系统的药物。HBS使客户能够满足法规和质量测试要求,从而将其候选药物从开发转向商业化。
对生物制药的需求正在增长,并且该行业正在迅速采用外包策略,以作为满足不断升级的监管要求的一种方式。凭借在止血方面的丰富经验,HBS能够很好地协助开发影响凝血系统的药物产品。